Calcium channel blockers show potential to restore cerebral blood flow in Alzheimer’s disease

Targeting calcium channels in pericytes may improve blood flow in Alzheimer’s disease, addressing early vascular dysfunction linked to cognitive deficits.

Bayer looks to expand Kerendia label to include heart failure – Pharmaceutical Technology

The studies will receive sponsorship from the non-profit academic research organisation, CPC Clinical Research, with funding from Bayer. Image Credit: nitpicker / Shutterstock. Bayer has

September 1, 2023

WHO considers adding ‘noma,’ a rare childhood disease, to its list of neglected conditions

It’s a disease of children living in extreme poverty. Its cause is uncertain. So is the number of children it affects. But soon, the devastating

October 25, 2023

Largest genetic study of epilepsy finds new risk genes

The largest genetic study of its kind, coordinated by the International League Against Epilepsy, including scientists from FutureNeuro at RCSI University of Medicine and Health

August 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.